These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The relevance of migraine in the clinical spectrum of mitochondrial disorders. Terrin A; Bello L; Valentino ML; Caporali L; Sorarù G; Carelli V; Maggioni F; Zeviani M; Pegoraro E Sci Rep; 2022 Mar; 12(1):4222. PubMed ID: 35273322 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction and migraine: evidence and hypotheses. Sparaco M; Feleppa M; Lipton RB; Rapoport AM; Bigal ME Cephalalgia; 2006 Apr; 26(4):361-72. PubMed ID: 16556237 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Headache in Patients With Mitochondrial Disease: A Cross-Sectional Study. Kraya T; Deschauer M; Joshi PR; Zierz S; Gaul C Headache; 2018 Jan; 58(1):45-52. PubMed ID: 29139113 [TBL] [Abstract][Full Text] [Related]
10. Energy Metabolism Impairment in Migraine. Cevoli S; Favoni V; Cortelli P Curr Med Chem; 2019; 26(34):6253-6260. PubMed ID: 29932030 [TBL] [Abstract][Full Text] [Related]
11. [Genetic aspects of migraine]. Kopishinskaya SV; Gustov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):124-129. PubMed ID: 26356526 [TBL] [Abstract][Full Text] [Related]
16. Migraine in mitochondrial disorders: Prevalence and characteristics. Vollono C; Primiano G; Della Marca G; Losurdo A; Servidei S Cephalalgia; 2018 May; 38(6):1093-1106. PubMed ID: 28762753 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Di Lorenzo C; Pierelli F; Coppola G; Grieco GS; Rengo C; Ciccolella M; Magis D; Bolla M; Casali C; Santorelli FM; Schoenen J Neurology; 2009 May; 72(18):1588-94. PubMed ID: 19414726 [TBL] [Abstract][Full Text] [Related]
18. A possible role for mitochondrial dysfunction in migraine. Stuart S; Griffiths LR Mol Genet Genomics; 2012 Dec; 287(11-12):837-44. PubMed ID: 23052833 [TBL] [Abstract][Full Text] [Related]
19. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas K; Robotka H; Toldi J; Vécsei L J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670 [TBL] [Abstract][Full Text] [Related]
20. Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion. Scott BR; Uomoto JM; Barry ES Headache; 2020 Mar; 60(3):526-541. PubMed ID: 31898813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]